Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jul 01, 2006 (Vol. 26, No. 13)

Ion Adventure

  • Attractive graphics, good writing
  • Not enough online content
I like the full name of this site—Ion Adventure in the Heartland. It conjures up some very interesting images and the word adventure gives it a fun twist. That’s an important perspective for a topic such as electrophysiology that some people might not otherwise find all that interesting. With a deft touch, Dale Dubin, M.D., an expert in EKGs, leads visitors through selected topics from his recently released book. Like other book promo sites, Ion Adventure suffers from inadequate online coverage, but this is not totally surprising given the desire to sell books. If the actual book is as informative as the few pages on this Website, it will provide important educational material and just might make this sometimes-dreary subject interesting to read about.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »